Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods of inducing cytotoxic immune response and recombinant simian ademovirus compositions useful therein

A technology of simian adenovirus and recombinant adenovirus, applied in the direction of complete cells/viruses/DNA/RNA components, medical materials derived from viruses/bacteriophages, viruses, etc.

Inactive Publication Date: 2004-08-04
THE WISTAR INST OF ANATOMY & BIOLOGY +1
View PDF5 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, higher doses may be associated with other unwanted side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of inducing cytotoxic immune response and recombinant simian ademovirus compositions useful therein
  • Methods of inducing cytotoxic immune response and recombinant simian ademovirus compositions useful therein

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0030] C. Preparation of Recombinant Virus Particles

[0031] Suitable recombinant simian adenoviruses are prepared using methods well known to those skilled in the art, such as those described in US Pat. No. 6,083,716. In constructing recombinant simian adenoviruses for delivery of heterologous molecules to a subject (eg, a human, canine, feline, or other mammal), the adenoviral nucleic acid sequences employed in the vector are available from a variety of simian sources.

[0032] Vectors containing simian (eg, chimpanzee) adenoviral sequences lacking the simian adenoviral sequences required for the production of infectious recombinant viral particles can be used in combination with a helper virus or vector. The helper virus provides the gene products required for simian adenovirus infectivity and propagation. When selective deletions of one or more simian adenovirus genes are made in functional viral vectors, these deleted gene products can be provided during viral vector pr...

Embodiment 1

[0070] Example 1 - Preparation of E1 deletion vector based on chimpanzee adenovirus C68

[0071] A replication-defective form of C68 was isolated for gene transfer. A typical strategy to obtain E1-deleted recombinants is by homologous recombination in E1-expressing cell lines. The first step is to generate a plasmid containing m.u.0 to 1.3 followed by the addition of a minimal gene expressing enhanced green fluorescent protein (GFP) under the CMV promoter and the C68 sequence spanning 9-16.7 m.u. The linearized plasmid and the SspI digested C68 plasmid (cut by SspI at 3.6 m.u, leaving 4644 bp for homologous recombination) were co-transfected into a cell line expressing El. Experiments were initially performed with 293 cells carrying human Ad5 E1 and it was hoped that this would be sufficient for trans complementation. In fact, the plaques formed provided the desired recombinants. The resulting vector was named C68-CMV-GFP.

[0072] Strategies to improve recombinant product...

Embodiment 2

[0081] Example 2 - Antigen Expression (Gag Secretion) in TK Cells Infected with Simian Adenovirus Vaccine Constructs

[0082] As described in Example 1 and Z.Q.Xiang, et al., Virol.219, 200 (196), recombinant chimpanzee adenovirus strain 68 (Adchimp68) and human adenovirus strain 5 (Adhu5), both carrying modified HIV - Nucleotide sequence of the truncated gag gene of clade B. The transcripts of HIV-1's structural proteins (including gag) contain genetically unstable elements and require the presence of rev protein in order to export the nucleus and efficiently express in the cytoplasm (S. Schwartz et al., J Virol 66, 7176 (1992); S. Schwartz et al., J Virol 66, 150-159 (1992); G. Nasioulas et al., J Virol 68, 2986 (1994)). Adenoviruses rely on nuclear transcription and thus require rev to express HIV-1 proteins. To avoid dependence on Rev, the genetic instability element in the codon-modified gag sequence was removed by site-directed mutagenesis (R. Schneider et al., J Virol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a method of inducing a CD8+ T cell response against a selected molecule by delivering the molecule via a recombinant simian adenovirus. The present invention also provides a method for inducing alpha interferon and beta interferon by delivering a recombinant simian adenovirus to a subject. The methods and compositions of the invention are particularly suitable for use in the prevention and treatment of human immunodeficiency virus, human papillomavirus infections and cancer treatment.

Description

[0001] This work was supported by grants P30 DK47757-08 and P01 HL 59407-02 from the National Institutes of Health and grant AI 49766-01 from NIAID. The US Government has certain rights in this invention. Background of the invention [0002] Human serotype 5 recombinant adenoviruses have been tested as vaccine vectors for various antigens derived from viruses, parasites or tumor cells. The results were encouraging, as the E1-deleted adenoviral recombinants elicited an immune response against the transgene product. Adenovirus serotype 5 (Ad5) is a ubiquitous cold virus that infects most people within the first year of life. The inventors have discovered that pre-existing immunity to common human serotypes reduces the efficacy of adenovirus recombinant vaccines based on viral homologous serotypes. In some instances, this reduced potency can be overcome by delivering higher doses of human recombinant adenovirus. However, higher doses may be associated with other undesirable si...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K48/00A61K35/76A61K39/00A61K39/12A61K39/205A61K39/23A61K39/235A61P31/12A61P31/18C07K14/025C07K14/08C07K14/145C07K14/16C12N7/04C12N15/861C12Q1/70
CPCA61K2039/5256C12N2760/20122C12N2740/16122C12N2710/10343C07K14/005C12N7/00A61K39/235A61K2039/57C12N2740/16134C12N2830/55C12N15/86A61K2039/53C12N2830/002A61K48/00C12N2710/10362A61K39/00C12N2760/20134A61P31/12A61P31/18A61P37/04Y02A50/30
Inventor H·C·J·埃特尔J·M·威尔逊
Owner THE WISTAR INST OF ANATOMY & BIOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com